tiprankstipranks
Clinica Baviera, SA (GB:0GWJ)
LSE:0GWJ

Clinica Baviera (0GWJ) Income Statement

0 Followers

Clinica Baviera Income Statement

Last quarter (Q3 2022), Clinica Baviera's total revenue was €42.07M, an increase of 9.56% from the same quarter last year. In Q3, Clinica Baviera's net income was €5.02M. See Clinica Baviera’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
€ 192.55M€ 172.73M€ 122.63M€ 124.33M€ 109.29M€ 99.88M
Cost of Revenue
-€ 21.48M€ 15.25M€ 14.69M€ 12.83M€ 11.33M
Gross Profit
-€ 151.25M€ 107.37M€ 109.65M€ 96.46M€ 88.55M
Operating Expense
€ 128.64M€ 111.78M€ 86.86M€ 91.25M€ 79.48M€ 74.92M
Operating Income
€ 42.42M€ 39.46M€ 20.51M€ 18.39M€ 16.98M€ 13.62M
Net Non Operating Interest Income Expense
€ -427.11K€ -455.11K€ -527.09K€ -589.88K€ -160.66K€ -196.48K
Other Income Expense
------
Pretax Income
€ 41.88M€ 38.90M€ 20.19M€ 17.79M€ 16.81M€ 13.43M
Tax Provision
€ 11.65M€ 10.97M€ 6.05M€ 4.89M€ 4.90M€ 3.55M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
€ 29.69M€ 27.39M€ 13.94M€ 12.79M€ 11.83M€ 9.77M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
-€ 1.45M€ 2.03M€ 1.18M€ 8.19M€ 7.53M
Total Expenses
€ 150.13M€ 133.27M€ 102.12M€ 105.94M€ 92.31M€ 86.26M
Net Income From Continuing And Discontinued Operation
€ 29.69M€ 27.39M€ 13.94M€ 12.79M€ 11.83M€ 9.77M
Normalized Income
€ 29.69M€ 27.44M€ 13.94M€ 12.86M€ 11.84M€ 9.77M
Interest Expense
€ 125.00K€ 458.30K€ 535.09K€ 591.69K€ 164.11K€ 202.17K
EBIT
€ 42.31M€ 39.36M€ 20.72M€ 18.38M€ 16.97M€ 13.63M
EBITDA
€ 57.05M€ 53.45M€ 34.27M€ 31.61M€ 21.93M€ 18.02M
Currency in EUR

Clinica Baviera Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis